[Skip to Content]
[Skip to Content Landing]
Views 151
Citations 0
Observation
February 2017

Topical Diphencyprone Immunotherapy for Painful Nodular Acral Recurrence of Kaposi Sarcoma

Author Affiliations
  • 1Section of Dermatology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
  • 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
  • 3Istituto Dermopatico dell’Immacolata IRCCS, Rome, Italy
JAMA Dermatol. 2017;153(2):234-235. doi:10.1001/jamadermatol.2016.4301

Goals of classic treatment of Kaposi sarcoma (KS) without visceral involvement are to control symptoms and improve function. Localized lesions are managed by surgical excision, cryotherapy, intralesional chemotherapy, or radiotherapy, which can be painful and are physician-applied treatments. Recently, less demanding treatments based on topical drugs have been proposed.14

First Page Preview View Large
First page PDF preview
First page PDF preview
×